MENLO PARK, CA, October 14, 2020— LamdaGen Corporation, a developer of plasmonic biosensor systems for diagnostics, announced the European Patent Office (EPO) has granted its patent application entitled “Digital LSPR for Enhanced Assay Sensitivity” which enables highly sensitive and quantitative point of care (POC) diagnostic testing.
LamdaGen’s nano-based detection technology has been integrated into the company’s LAuRA Digital Diagnostic Platform. The rapid immuno-based POC platform couples the high sensitivity and quantitation of lab-based ELISA tests with the simplicity and speed of lateral flow assays (LFA), thus making it ideal for high sensitivity POC diagnostic application.
“This patent is central to our LAuRA digital platform andunderscores LamdaGen’s unique ability to harness the novel characteristics of advanced plasmonics to significantly amplify signal, which enables enhanced detection in rapid diagnostics,” commented Randolph Storer, CEO and Co-Founder of LamdaGen Corporation. “We are developing several infectious disease assays on the LAuRA platform that outperform commercial tests in side-by-side comparisons in terms of sensitivity and precision.”
LamdaGen’s Plasmonic Amplification Technology has been integrated into the LAuRA POC Diagnostic System. The simple and easy-to-use cartridge/reader system is aimed at improving health and wellness by making diagnostics more accessible and convenient at clinics, mobile testing sites, pharmacies and anywhere rapid on-site turnaround time is desired.
About LamdaGen Corporation
LamdaGen Corporation is a Silicon Valley developer of nano-based biosensors and powerful testing systems. The company’s mission is to develop and commercialize innovative technologies for disease detection wherever, and whenever, they are needed. We do this by focusing on providing high sensitivity global point of care diagnostics that are fast, simple, and available to improve human health and wellness. For additional information, please visit www.lamdagen.com or email 4info@lamdagen.com